Retatrutide, by Soma Chems , is receiving increasing attention as a potential therapy for obesity management . This dual-action compound merges the activity of a GLP-1 receptor stimulant and a GIP receptor stimulant, aiming to not only promote metabolic improvements but also target related metabolic conditions . Initial soma chems retatrutide clini